Gene transfer into hepatocytes and human liver tissue by baculovirus vectors.
Gene therapy of liver diseases requires the development of efficient vectors for gene transfer in vivo. Retroviral and adenoviral vectors have been shown to deliver genes efficiently into hepatocytes in vitro and in vivo. However, these vectors do not allow for exclusive infection of the liver which would be highly advantageous for in vivo gene therapy strategies. We have recently demonstrated that genetically modified baculoviruses (Autographa californica nuclear polyhedrosis virus) efficiently deliver genes into cultured cells and have a strong preference for hepatocytes of different origin. Baculoviral gene transduction efficiency into human hepatocytes was determined to approach 100% and expression levels are high, provided that gene expression is controlled by mammalian promoters. In this report, we present further properties of baculoviruses regarding their use for hepatocyte gene transfer. Baculovirus-mediated gene expression declines rapidly in the hepatocellular carcinoma cell line Huh7 and more slowly in primary cultures of mouse hepatocytes. Direct application of baculoviruses for gene delivery to the liver in vivo is hampered by serum components, presumably by complement. However, we demonstrate here that baculoviral gene transfer is feasible in ex vivo perfused human liver tissue. This result suggests the development of a strategy using baculoviral vectors for liver-directed gene therapy.
Sandig
V
V
HepaVec GmbH, Berlin-Buch, Germany.
Hofmann
C
C
Steinert
S
S
Jennings
G
G
Schlag
P
P
Strauss
M
M
D000818:Animals; D002460:Cell Line; D015870:Gene Expression; D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D006168:Guinea Pigs; D006801:Humans; D007700:Kinetics; D008099:Liver / Q000166:cytology / Q000378:metabolism*; D017924:Nucleopolyhedroviruses / Q000235:genetics*; D010477:Perfusion; D011817:Rabbits; D011995:Recombination, Genetic; D018411:Spodoptera / Q000166:cytology; D014407:Tumor Cells, Cultured